key: cord-0746845-vw8rrhxj authors: Gelman, Ram; Potruch, Assaf; Oster, Yonatan; Ishay, Yuval; Gur, Chamutal; Beeri, Ronen; Strahilevitz, Jacob title: Native aortic valve Staphylococcus warneri endocarditis after COVID‐19 infection: a case report and a review of literature date: 2022-03-11 journal: APMIS DOI: 10.1111/apm.13217 sha: 3c6854999864ed9fb06bfc4203b5c1c75d9ea6f9 doc_id: 746845 cord_uid: vw8rrhxj We report a case of Staphylococcus warneri native valve endocarditis in an immunocompetent healthy adult, without known risk factors for infective endocarditis, two months following COVID‐19 infection, who recovered with conservative treatment. Additionally, we reviewed previous cases of native valve endocarditis caused by Staphylococcus warneri and summarized the main clinical implications. space at the left midclavicular line. Specifically, he had no wounds that could be a source of skin flora entry. Initial laboratory workup, showed elevated creatinine of 139 µmol/L (normal -62-115 µmol/ L), hypokalemia 2.8 mmol/L (normal -3.5-5.1 mmol/L), normal white blood cell count of 7000 U/L (normal -4,000-10,500 U/L) with lymphopenia of 500 U/L (normal -1070-3120 U/L). The C-reactive protein (CRP) was elevated at 23.5 mg/dL (normal <0.5 mg/dL), erythrocyte sedimentation rate (ESR) was elevated at 38 (normal [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , and ferritin was also elevated at 588 ng/ml (normal 22-322 ng/ml). Liver enzymes were normal, as was the international normalized ratio (INR) and the D-dimer levels. Electrocardiogram (ECG) showed normal sinus rhythm with a normal P-R interval and no signs of ischemia or myocarditis. Chest X-ray and computerized tomography scan of the head, chest, abdomen, and pelvis were unremarkable. A nasopharyngeal swab tested by RT-PCR for SARS-CoV-2 was negative ([N, Nsp2 genes], NeuMoDx TM SARS-CoV-2 assay, NeuMoDx Molecular, Inc). Due to the aforementioned murmur, a transthoracic echocardiography (TTE) was performed and demonstrated a possible aortic valve vegetation ( Figure 1) . A transesophageal echocardiography (TEE) performed two days later revealed an oblong echogenic mobile mass, measuring up to 13 mm in length on the aortic valve, attached to the left coronary cusp on its ventricular aspect, and a second vegetation on the non-coronary cusp of the aortic valve measuring 8 mm in length. There was no aortic regurgitation or outflow obstruction. Two sets of blood cultures, the first taken upon admission and the second drawn three days after, grew (time to positivity 13 h and 41 minutes) a coagulase-negative Staphylococcus that was identified by matrix-assisted laser desorption/ionization timeof-flight (MALDI-TOF) (VITEK Ò MS, bioM erieux) as S. warneri (99.9% confidence). The identification was verified by sequencing the 16S rDNA real-time PCR amplicon as previously described, sequencing results were analyzed with Geneious bioinformatics software and compared to the National Center for Biotechnology Information (NCBI) world database for bacterial species (International Nucleotide Sequence Database Collaboration) [4] . Following the CLSI breakpoints [5] , the isolate was susceptible to oxacillin/methicillin (MIC ≤0.25 mcg/mL), gentamicin (≤0.5 mcg/mL), rifampicin (≤0.5 mcg/mL), clindamycin (≤0.25 mcg/mL), and trimethoprim-sulfamethoxazole (≤10 mcg/mL). A SARS-CoV-2 IgG serological test (LIAISON Ò SARS-CoV-2 IgG, DiaSorin) was positive (45.7 AU/ml, positive value ≥15 AU/mL), thus confirming prior infection. Immunologic studies included normal complement and rheumatoid factor levels and negative antinuclear antibody. HIV testing was negative. A diagnosis of endocarditis with two major modified duke criteria [6] was made, and the patient was empirically treated with intravenous vancomycin and ceftriaxone. Upon receipt of susceptibility results, treatment was changed to cefazolin. The patient was discharged after 14 days and completed a six weeks treatment via a peripherally inserted central catheter. At follow-up, post-completion of the antibiotic course, the patient has recovered clinically. TTE performed at that time demonstrated unchanged vegetation upon the aortic valve. Staphylococcus warneri is a gram-positive bacterium, a member of the coagulase-negative staphylococci family. It is a part of the normal skin flora, present in approximately 50% of healthy adults [7] . Compared with other members of the coagulasenegative staphylococci, S. warneri is considered to be a weak pathogen, usually causing a disease in immunocompromised patients or in those with prosthetic devices [3] . The majority of patients with CoNS NVE undergo surgery, more than in patients with NVE due to S. aureus or viridans group streptococci [8] . A literature review of former cases describing NVE caused by S. warneri, yielded a total of 11 reports in adults as shown in Table 1 . Dan et al. [9] were the first to describe a case of S. warneri NVE in 1984 in a young patient who underwent vasectomy two weeks prior. The patient age [11] 272 range in the cases reviewed was 28 to 79, with a male predominance-eight of the 11 cases. Interestingly, it appears that an increase in cases reported had occurred in the last two years, with five of the 11 cases taking place from the end of 2019 to this day. Five of the previous cases have shown damage to more than one heart valve at the time of diagnosis, with three cases requiring a surgical intervention. Mortality occurred in only one case [10] . The rest of the cases ended with good clinical outcome, excluding one case in which the long-term outcome has not been specified [11] . Wood et al. [12] were the first to describe a patient with no discernable risk factors other than a hip replacement performed a year prior to the development of S. warneri NVE. Since then, with the exception of a single case report [13] , in all previous cases, the patient had either a pre-existing degenerative valvular condition that made him susceptible to NVE, or a known risk factor for acquiring CoNS bacteremia such as intravascular devices [14] , skin puncture, or immunocompromised state. In two cases, recent orthopedic prosthetic implants (prosthetic joint and a lumbar disc) were mentioned as possible source, and subsequently refuted because there was no evidence of prosthesis infection at the time of the endocarditis [12, 15] . Our case is unique in the sense that a young healthy patient without any signs of previous valvular condition, and without any known risk factors, developed S. warneri NVE, and fully recovered with conservative antibiotic treatment, without the need for surgical intervention. Non-bacterial thrombotic endocarditis (NBTE) is a form of non-infective endocarditis that can develop in patients with risk factors [16] . It is the result of fibrin and platelets deposition on the heart valves and is associated with different malignancies and inflammatory conditions that lead to a procoagulant state [17] . NBTE is an under-diagnosed condition, found mostly in autopsies, where its incidence is approximately 1-3.7% [18, 19] . The presumed pathophysiology of NBTE begins with inflammation causing endothelial damage, creating a thrombogenic surface and leading to thrombi on the valvular surface [20] . When transient bacteremia occurs in patients with NBTE, the bacteria may adhere to these deposits, where it multiplies and result in infective endocarditis [21] . The COVID-19 pandemic caused by SARS-CoV-2, created a dramatic impact on global health, affecting millions of people worldwide [22] . COVID-19 is known to cause hypercoagulable and hyperinflammatory states [23] . This hypercoagulable state may cause arterial and venous thrombi, as well as microthrombi, damaging the endothelium [24] . The combination of hypercoagulability, as well as increased inflammatory reaction, may give rise to NBTE, disposing patients to IE [25] [26] [27] . A large systemic review of autopsies done on patients with COVID-19 infection has shown the presence of endothelial inflammation, with a procoagulant state and tissue injury of the endothelial cells [28] . Our patient may possibly represent a "missing link" between COVID-19 followed by IE [29, 30] . Possibly, the low rate of TEE performed on COVID-19 patients, due to the hypothetical risk of disease transmission to other patients and healthcare workers [31] , may hide the true incidence of this phenomenon. We have herein reported a case of native valve endocarditis caused by S. warneri occurring in a healthy nineteen-year-old man without any prosthesis, no history of skin puncture, no previous valvular condition, and no indication of immunocompromise. The patient was treated conservatively with antibiotics without indication for surgery and fully recovered. This article points out that low-virulence bacteria can be the cause of NVE, as demonstrated by the increasing number of cases of S. warneri NVE being reported worldwide. Clinicians should have a high level of suspicion when CoNS grows in consecutive blood cultures. Additionally, clinicians should be aware of the potential risk factor of NBTE that may arise from COVID-19 infection. COVID-19 patients may be at greater risk for these thrombotic complications, and therefore susceptible to IE. TEE and other diagnostic tests should not be avoided, when clinically indicated. Native-valve infective endocarditis Coagulase-negative staphylococci An unusual presentation of endocarditis caused by Staphylococcus warneri Breast implant Q fever as a source of in-hospital transmission Performance standards for antimicrobial susceptibility testing, 30th edn (supplement M100) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Manual of clinical microbiology, 5th edn Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis Endocarditis caused by Staphylococcus warneri on a normal aortic valve following vasectomy Clinical significance of Staphylococcus warneri bacteremia A case of subcortical hemorrhage due to infective endocarditis caused by Staphylococcus warneri without fever and leukocytosis Vertebral osteomyelitis and native valve endocarditis caused by Staphylococcus warneri Native valve endocarditis caused by Staphylococcus warneri: an unusual presentation Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature Staphylococcus warneri endocarditis after implantation of a lumbar disc prosthesis in an immunocompetent patient Nonbacterial thrombotic endocarditis: a review A Contemporary 20-year cleveland clinic experience of nonbacterial thrombotic endocarditis: etiology, echocardiographic imaging, management, and outcomes Endocarditis tromb otica no bacteriana: estudio cl ınico-patol ogico de una serie necr opsica. Revista Española de Cardiolog ıa Overview and comparison of infectious endocarditis and non-infectious endocarditis: a review of 814 autoptic cases Marantic endocarditis and disseminated intravascular coagulation with systemic emboli in presentation of pancreatic cancer Endocarditis of natural and prosthetic valves: treatment and prophylaxis Another decade, another coronavirus Platelets and COVID-19 Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease Nonbacterial thrombotic endocarditis: a presentation of COVID-19 Cardiac compromise in COVID-19 Marantic endocarditis associated with COVID-19: a rare case report of a potentially deadly disease COVID-19 and the heart: a systematic review of cardiac autopsies Covid-19 infection predisposing endocarditis complicated by the challenges of patient care in a pandemic Coronavirus disease 2019 infection as a risk factor for infective endocarditis Restricted use of echocardiography in suspected endocarditis during covid-19 lockdown: a multidisciplinary team approach An unusual presentation of native valve endocarditis caused by Staphylococcus warneri Native valve endocarditis with Staphylococcus warneri Native valve endocarditis due to Staphylococcus warneri developing in a patient with type 1 diabetes Native mitral valve infective endocarditis caused by Staphylococcus warneri: a case-based review The authors have no conflicts of interest to declare. All authors made a substantial contribution to the case report and approved the final version of the manuscript. Written informed consent was obtained from the patient for publication of this case report.